It’s nothing new in Canada when the big companies of U.S acquires or merge with Canadian operated company for the better opportunities to make a profit and achieve the strategic goals of the company, recently I read an article about that the McKesson Corporation agreed to acquire Rexall Health from Katz group. (Tracer, 2016) It’s a huge acquisition in pharma industry especially after the Loblaw’s acquires the shopper’s drugmart in 2013. So let’s take a look at both companies profile. McKesson Corporation is an American company distributing pharmaceuticals at a retail sale level and providing health data equipment, medical materials, and care management tools in Canada (Wikipedia, 2016) and they are currently struggling with their supply chain
…show more content…
In my point of view it’s far greater than the measure of the deals recommends. Truth be told, it speaks to both an open door and a commitment for McKesson-Rexall to enter the space race, alongside Loblaw’s-Shoppers Drug Mart, to fundamentally enhance community-based primary care and in the meantime profit will increase by reducing the cost of delivery of the product into the store because this deal will impact the transportation cost of the medicine which both companies are struggling because what they normally do McKesson transport the medicine to Rexall pharma with the help 3PL logistics. It's one of those uncommon open doors for an aggregate win-win of group and industry since they can't make profit until they convey better community care.
McKesson corp. is the big supplier to Rexall Pharma and also the competitor to each other in Canadian market so if they come together with each other its obviously cut the cost of the operation plus they can use the data to decide or see that what to buy and where they can buy and where to put the stocks in retail’s. It’s also important in terms of customers because it will enhance their options to buy the medicines on addition to that the McKesson-Rexall deal could prompt a radical change of drug store as the essential conveyance vehicle for community healthcare in Canada. (Pharmacy,
In my point of view it’s far greater than the measure of the deals recommends. Truth be told, it speaks to both an open door and a commitment for McKesson-Rexall to enter the space race, alongside Loblaw’s-Shoppers Drug Mart, to fundamentally enhance community-based primary care and in the meantime profit will increase by reducing the cost of delivery of the product into the store because this deal will impact the transportation cost of the medicine which both companies are struggling because what they normally do McKesson transport the medicine to Rexall pharma with the help 3PL logistics. It's one of those uncommon open doors for an aggregate win-win of group and industry since they can't make profit until they convey better community care.
McKesson corp. is the big supplier to Rexall Pharma and also the competitor to each other in Canadian market so if they come together with each other its obviously cut the cost of the operation plus they can use the data to decide or see that what to buy and where they can buy and where to put the stocks in retail’s. It’s also important in terms of customers because it will enhance their options to buy the medicines on addition to that the McKesson-Rexall deal could prompt a radical change of drug store as the essential conveyance vehicle for community healthcare in Canada. (Pharmacy,